Genetic variants in LRGI1 have been previously shown to be linked to birth weight, blood pressure and cardiovascular endpoints50–53, while methylation of CpG sites in LRIG1 has been linked to obesity in children, as well as birthweight and maternal adiposity54–56. Here, LRIG1 is linked to obesity disorder.